-ONCONOVA ANNOUNCES PRESENTATION OF MECHANISM OF ACTION STUDIES OF RIGOSERTIB COMBINATION WITH AZACITIDINE AT AMERICAN ASSOCIATION FOR CANCER RESEARCH EPIGENETICS CONFERENCE

Press/Media

Period7 Mar 2018

Media coverage

1

Media coverage

  • Title-ONCONOVA ANNOUNCES PRESENTATION OF MECHANISM OF ACTION STUDIES OF RIGOSERTIB COMBINATION WITH AZACITIDINE AT AMERICAN ASSOCIATION FOR CANCER RESEARCH EPIGENETICS CONFERENCE
    Media name/outletENP Newswire
    Date7/03/18
    PersonsLewis Silverman